Alzheimer’s wonder drug delays disease for four years

Some patients involved in trials for lecanemab even saw cognitive scores improve

giovedì 31 luglio 2025 New tab

798 words~4 min read

Some patients involved in trials for lecanemab even saw cognitive scores improve

Copy link

twitter

facebook

Other newsrooms on this story

· 3 sources

· 3 sources

Patients in the earliest stage of the disease saw little to no decline over four years

independent.co.uk9 mesi fa

Trials suggest ‘game-changing’ treatment could be the most powerful weapon yet against dementia

telegraph.co.uk9 mesi fa

Injection of nanoparticles “reminds” blood-brain barrier to work properly, allowing brain cells to communicate again

telegraph.co.uk7 mesi fa

Das neue Alzheimer-Medikament Lecanemab kann den Verlauf der Krankheit im Frühstadium um einige Monate verzögern. Seit dem 1.…

faz.net7 mesi fa

Researchers hope findings could help delay symptoms by five or six years

independent.co.uk8 mesi fa

Biogen said signals sugget the treatment decreases levels of tau and slows cognitive decline, particularly at the lowest dose.

cnbc.com1 h fa